The pharmacological management of asthma has changed considerably in recent decades, as it has come to be understood that it is a complex, heterogeneous disease with different phenotypes and endotypes. It is now clear that the goal of asthma treatment should be to achieve and maintain control of the... disease, as well as to minimize the risks (of exacerbations, disease instability, accelerated loss of lung function, and adverse treatment effects). That requires an approach that is personalized in terms of the pharmacological treatment, patient education, written action plan, training in correct inhaler use, and review of the inhaler technique at each office visit. A panel of 22 pulmonologists was invited to perform a critical review of recent evidence of pharmacological treatment of asthma and to prepare this set of recommendations, a treatment guide tailored to use in Brazil. The topics or questions related to the most significant changes in concepts, and consequently in the management of asthma in clinical practice, were chosen by a panel of experts. To formulate these recommendations, we asked each expert to perform a critical review of a topic or to respond to a question, on the basis of evidence in the literature. In a second phase, three experts discussed and structured all texts submitted by the others. That was followed by a third phase, in which all of the experts reviewed and discussed each recommendation. These recommendations, which are intended for physicians involved in the treatment of asthma, apply to asthma patients of all ages.
more
This study aimed to determine the drug resistance profile of Mycobacterium tuberculosis in Mozambique and concludes that M. tuberculosis resistance to antituberculosis drugs is high in Mozambique, especially in previously treated patients. The frequency of M. tuberculosis strains that were resistant... to isoniazid, rifampin, and streptomycin in combination was found to be high, particularly in samples from previously treated patients.
J Bras Pneumol. 2014;40(2):142-147
more
Washington, D.C., EUA, del 26 al 30 de septiembre del 2016
Punto 4.10 del orden del día provisional
CD55/14 8 de julio del 2016
Original: inglés
Guía Clínica
Versión actualizada - 2010
Informe
Bogotá, 13-14 de abril del 2015
El Chagas, considerado un problema relevante de Salud Pública, dispone de medidas eficaces
para su prevención, diagnóstico, tratamiento y control. El desafío es la organización integral de
la respuesta para minimizar el impacto en la salud de la población
Componente del Juego de herramientas para la prevención: “Cómo reconocer las deficiencias de nacimiento”
A Consumer Guide
Printed 2006
Revised 2007, 2008, 2011, 2014, and 2015
- Guía de recomendaciones - 2da. Edición. Esta guía cuenta con recomendaciones e información fundamental.
SARS-CoV-2 infection and pulmonary tuberculosis: analysis of the situation in Peru
Instructivo para entrevistador/a. Accessed May 30, 2017